Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Applying a special compound can promote hair growth without harmful side effects.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Skin has specialized touch receptors that can tell different sensations apart.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

DHT stops hair regrowth in mice, similar to human hair loss.

Finasteride may improve prostate cancer treatment outcomes.

The type 3 IP3 receptor is important for controlling hair loss and growth.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Dutasteride and finasteride affect different cell types differently.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.